Blake Aftab - Oct 12, 2021 Form 3/A - Amendment Insider Report for Adicet Bio, Inc. (ACET)

Role: Chief Scientific Officer
Signature: /s/ Nick Harvey, as Attorney-in-Fact
Stock symbol: ACET
Transactions as of: Oct 12, 2021
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 10/14/2021, 05:15 PM
Date Of Original Report: Oct 13, 2021
Next filing: Jan 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ACET	Stock Option (Right to Buy)							Oct 12, 2021	Common Stock	50K	$15.93	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares shall vest on the first anniversary of April 5, 2021 (the "Vesting Commencement Date") and as to the remaining 75% of such shares in thirty-six (36) equal monthly installments following the first anniversary of the Vesting Commencement Date; provided that the option holder remains continuously engaged by the Company on each such date.

Remarks:

This Form 3/A is being filed to include Exhibit 24, a Power of Attorney for the Reporting Person, which was inadvertently omitted from the original Form 3 filing on October 13, 2021. Exhibit: Power of Attorney